overdose on semaglutide Ozempic Overdoses Are the Rise: What to Know About Symptoms GLP-1 weight-loss drugs: PA, NJ

1D and 2D) and GIP (data not shown) did not reach statistical significance in both groups

Boosts Brain Health and May Lower Dementia Risk Research reveals a brain-protective role for GLP-1 medications that extends well beyond their metabolic effects

The outcome represents a win for Health Secretary Robert F Kennedy Jr., who has publicly supported peptide therapies, and the broader wellness and longevity industry, which stands to profit substantially

doi: 10.1080/14737175.2023.2173575

Katharina Timper Klinik fr Endokrinologie, Diabetologie und Metabolismus Universittsspital Basel Petersgraben/Spitalstrasse 21 4031 Basel Bernd Schultes: Vortragshonorare und Beratungshonorare von Novo Nordisk und Eli Lilly, sowie finanzielle Forschungsuntersttzung durch Novo Nordisk